tardyferon

the uth hour at ers s 51.1% , te ld if et 24.5% , k 12.2% , 5 6.1% , #6 3.1% , alts 1.5% , ee 0.8% , nel giu gastrointestinal diseases if you experience any adverse effects 0.4% , talk to your doctor and pharmacist 0.2% , this also applies to any adverse reaction that wou mentioned in this leaflet 0.1% , you can also report the side effects directly via the national reporting system 0.0% , 5 0.0% , how to store tardyferon b9 0.0% , film-coated tablet? no special storage precautions 0.0% , keep this drug out from sight and reach of children 0.0% , do not use this medicine after date of expiry as shown on outside packaging 0.0% , the expiry date refers to the last day of this month 0.0% , do not dispose any medication in the sewage system and with household wastes 0.0% , ask your pharmacist to eliminate unused these measures are meant to protect the environment 0.0% , #6 0.0% , contents of packaging and other information what tardyferon b9 0.0% , film-coated tablets 0.0% , CONTAINS 0.0% , iron 0.0% , in form of dried ferrous sulfate 0.0% , folic acid 0.0% , for a film-coated tablet other components 0.0% , fondouk choucha 2013-b 0.0% , P 0.0% , 76-ben arous tunisia headquarters 0.0% , tunis 0.0% , last date to which this leaflet has been revised is september 2019 amm n° 0.0% , 9323023-boite de 90 0.0% , E460i 0.0% , E1505 0.0% , E553b 0.0% , ammoniomethacrylate copolymer type b 0.0% , ar a 0.0% , glycerol dibehenate 0.0% , coating 0.0% , sepilfilm lp010 0.0% , yellow iron red iron oxide 0.0% , E1505 0.0% , what is tardyferon b9 0.0% , film-coated tablet and content of the outside packaging? this drug is provided as a film-coated tablet 0.0% , box of 30 or 90 0.0% , manufacturer and holder of the marketing authorisation pierre fabre medicament production tunisie 0.0%